Publications by authors named "Steven Pirie-Shepherd"

Claim this Profile
P
Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images.
Sripad Ram, Pamela Vizcarra, Pamela Whalen, Shibing Deng, C L Painter, Steven Pirie-Shepherd

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Steven Pirie-Shepherd

Mol Cancer Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.
Kenneth G Geles, Yijie Gao, Andreas Giannakou, Latha Sridharan, Ting-Ting Yamin, Steven Pirie-Shepherd

Cell Rep Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors.
Lee S Rosen, Robert Wesolowski, Raffaele Baffa, Kai-Hsin Liao, Steven Y Hua, Steven Pirie-Shepherd

Invest New Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
Ignacio Garrido-Laguna, Ian Krop, Howard A Burris, Erika Hamilton, Fadi Braiteh, Steven Pirie-Shepherd

Int J Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients.
Steven R Pirie-Shepherd, Cory Painter, Pamela Whalen, Pamela Vizcarra, Marc Roy

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.
Florence T H Wu, Shan Man, Ping Xu, Annabelle Chow, Marta Paez-Ribes, Steven R Pirie-Shepherd

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft models.
Gallen Triana-Baltzer, Adam Pavlicek, Ariadne Goulart, Hanhua Huang, Steven Pirie-Shepherd

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs.
Ruth Muchekehu, Dingguo Liu, Mark Horn, Lioudmila Campbell, Joselyn Del Rosario, Steven R Pirie-Shepherd

Transl Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of a thrombospondin 1 mimetic CovX-body.
Lingna Li, Tom A Leedom, Janet Do, Hanhua Huang, JingYu Lai, Steven R Pirie-Shepherd

Transl Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
Hanhua Huang, Jing-Yu Lai, Janet Do, Dingguo Liu, Lingna Li, Steven Pirie-Shepherd

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of potent and stable placental-growth-factor-1-targeting CovX-bodies from phage display peptide discovery.
Kristen E Bower, Son N Lam, Bryan D Oates, Joselyn R Del Rosario, Emily Corner, Steven R Pirie-Shepherd

J Med Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.
Kalvin J Gregory, Bing Zhao, Diane R Bielenberg, Sami Dridi, Jason Wu, Steven Pirie-Shepherd

PLoS One· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective activity against proliferating tumor endothelial cells by CVX-22, a thrombospondin-1 mimetic CovX-Body.
Julia Coronella, Lingna Li, Kimberly Johnson, Steven Pirie-Shepherd, Giovanni Roxas

Anticancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1.
Jose C Juarez, Oscar Betancourt, Steven R Pirie-Shepherd, Xiaojun Guan, Melissa L Price

Clin Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.
Oliver Kisker, Shinya Onizuka, Christian M Becker, Michael Fannon, Evelyn Flynn, Steven Pirie-Shepherd

Neoplasia· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of human pancreatic cancer in mice with angiogenic inhibitors.
Daniela Prox, Christian Becker, Steven R Pirie-Shepherd, Ilhan Celik, Judah Folkman

World J Surg· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of angiogenesis by the hemostatic system.
Steven R Pirie-Shepherd

Front Biosci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis